Category
19 plain-language articles on cognitive support — the physiology, the compounds, and what the evidence actually shows.
19 articles
Brain fog that comes and goes
Some days the words are there. Other days there's a half-second pause where the noun should be, the sentence reroutes around it, and you spend the rest of the conversation hoping no one noticed. Some weeks you read a paragraph three times before it lands. Then it lifts. The good days return. Then it comes back. Brain fog that comes and goes isn't random, and it isn't in your head in the dismissive sense. It's a real physiological state, and its on-off pattern is the most useful diagnostic clue it gives you.
The brain fog that follows your cycle — the cognitive fluctuation no one mapped for you
There are days in the month when your mind is a precision instrument. You write fast, you hold the thread of a conversation without losing it, you do mental math in real time and the answer is there before you need it. You feel, in some basic cognitive sense, like yourself. And then there are other days — often predictable days, often a particular cluster of days — when you sit down to write the same kind of thing and the words are not there. Not gone exactly, just unavailable, like a file you know exists on a server you can't currently reach. Someone asks you a question in a meeting and you know the answer but it takes a beat too long to surface. You lose the noun in the middle of the sentence. You read the same paragraph three times and it doesn't stick. And the thing that makes this specific kind of awful is that you know what your mind is capable of, because you experienced it last week.
What people are reporting about Cortexin for cognitive support and recovery
This article summarizes experiences reported in public online communities including Reddit, longevity forums, and discussion boards. We are not advocating human use of any compound discussed here. Many of the peptides discussed are not FDA-approved for the uses described, and some are explicitly not approved for human or veterinary use. What follows is a synthesis of what people have reported, presented to give readers context on the public conversation — not as guidance, not as evidence of safety or efficacy, and not as a recommendation. Decisions about any compound should be made with a qualified prescribing provider after a full medical evaluation.
Cortexin in plain English — the bovine brain extract used in stroke recovery
You survive the stroke. That part goes as well as it can — the clot is caught early, the emergency intervention works, you're alive and you go home. What no one prepares you for is the months afterward. The word that used to come in half a second now takes four. You lose the thread of a sentence mid-paragraph. You read the same line three times and it doesn't stay. The neurologist says you should be seeing improvement, that the brain is plastic, that recovery takes time — and all of that is true, and none of it tells you what to do about the fact that your thinking feels like it's running through wet concrete.
Cortexin for cognitive decline and recovery — what Eastern European research has explored
He was fifty-three when the TBI happened. A car accident — nothing that looked catastrophic on the initial imaging, no bleeding that required surgery, discharged from the hospital within forty-eight hours with a list of follow-up appointments and instructions to rest. What nobody mentioned was that cognitive recovery from traumatic brain injury is not linear, is often incomplete, and has very few pharmacological tools backing it up in American medical practice. Three months later he was still struggling with processing speed, still losing words mid-sentence, still unable to hold complex work tasks together the way he used to. His neurologist offered reassurance and a referral to cognitive rehabilitation. That was the entire list.
FGL (FG loop) — the NCAM-derived peptide for memory
There is a moment in some people's experience of early cognitive decline — not the dramatic loss, but the earlier and stranger one — when the brain begins to feel like a place where connections don't quite hold. You reach for a thought and find the thought, but the thread that leads to the next thought, and the one after that, is loose. Not broken. Just not as taut as it used to be. It is a subtle wrongness, and it is easy to dismiss. Doctors, when you describe it, sometimes tell you that stress does this. They are not wrong. They are also not entirely right.
The kynurenine pathway — how chronic inflammation affects cognition and mood
You come down with a serious infection — flu, pneumonia, something that puts you in bed for a week. What nobody prepares you for is the cognitive and emotional texture of the illness: the flat affect, the inability to concentrate, the deep fatigue that feels different from ordinary tiredness, the mood that drops in ways a headache alone can't explain. You've been told this is your immune system fighting the infection. What you haven't been told is that a significant portion of what you're experiencing in your brain is a direct downstream consequence of what the immune system is doing to a single amino acid.
Intranasal Orexin A for fatigue and cognitive performance
The coffee isn't working. You've had two cups and you're waiting for something to shift — some brightening, some clearing of the cognitive fog — and the waiting itself feels like effort. This is a different kind of tired than the kind that comes from a late night or a hard workout. It's the low-arousal flatness that has been present for weeks, where the sleepiness isn't acute enough to justify going to bed at 2 p.m. but persistent enough that nothing feels quite sharp. Attention slides. Working memory drops things. The mental effort required for tasks that used to feel automatic has quietly doubled.
Orexin A and the wakefulness system — narcolepsy and the inverse story
The dog's name was Monty. He was a Doberman at the Stanford sleep laboratory, part of a colony that had been selectively bred for narcolepsy — sudden collapse into muscle paralysis, triggered by excitement or emotion, sometimes followed by what appeared to be dream-state episodes in an otherwise awake animal. Emmanuel Mignot had spent years trying to identify the genetic mutation responsible. The dogs offered a pure genetic model of narcolepsy. What Mignot found, after years of painstaking genetic work, changed the understanding of the condition entirely — and pointed toward a neurochemical system that nobody had yet described.
The oxytocin hype cycle — what the meta-analyses actually showed
The TED talk has been viewed several million times. The speaker describes oxytocin as the "moral molecule" — the chemical basis of empathy, of trust, of human goodness. He holds up the finding that a few puffs of intranasal oxytocin spray increase the money people entrust to strangers in an economic game, and he extrapolates to a vision of neurochemical kindness, of moral behavior bottled and delivered. The audience is charmed. The framing is elegant. And approximately a decade later, the careful second-wave replication literature has made the original claims look considerably more modest than that talk suggested.
Intranasal oxytocin — what the social cognition research has explored
You're in a conversation with someone you care about, but you can't quite access the warmth you know should be there. The words are right. The intent is there. But something is dialed down — some quality of felt connection, of being moved by the other person's presence — and you've been aware of it for months, maybe longer. It's most obvious at the moments when you want to feel close and instead feel like you're observing the closeness from a slight remove. You've chalked it up to stress, to the long workday, to the low-grade depletion that seems to have become baseline.
P21 — the cell-penetrating peptide for neurogenesis and tumor targeting
The same peptide appears in two very different scientific conversations, and the confusion this creates is genuine and worth addressing directly. In one conversation, researchers are discussing how to kill cancer cells from the inside — how to smuggle a toxic payload through a malignant cell's membrane and disrupt the energy machinery that keeps it dividing. In another conversation, researchers are discussing how to encourage new neurons to grow in a brain damaged by age or disease, and how to restore the learning and memory function that depends on that growth. The compound at the center of both conversations is P21, also referred to in some literature as P021. It is not that the compound does only one of these things while the other is a mistake. The biological reality is stranger than that: the same small peptide has research arcs in both oncology and cognitive neuroscience, for reasons that become clearer when you understand what cell-penetrating peptides actually do.
PACAP — the neuroprotective peptide also implicated in migraine
In 1989, Akira Arimura and colleagues at Tulane University were extracting ovine hypothalamic tissue — sheep brains, processed in quantity — looking for new signaling peptides. They were using an assay designed to detect compounds that elevated cyclic AMP in pituitary cells, a standard probe for peptides that activate adenylate cyclase. What they isolated was a thirty-eight amino acid neuropeptide, unlike anything previously characterized, that was among the most potent activators of adenylate cyclase in pituitary tissue they had ever encountered. They named it Pituitary Adenylate Cyclase-Activating Polypeptide. PACAP. The name was mechanistic rather than elegant, but it stuck.
PACAP in migraine research — and the antibody drugs aimed at blocking it
The migraine starts the same way it always does. Not with pain — that comes later. It starts with a narrowing, a sense that the world is slightly too bright and the sounds slightly too present, and then the drilling begins somewhere behind one eye and the only thing that helps is a dark room and complete stillness and waiting for it to be over. You've tried the triptans. They work sometimes. You've tried the preventives — topiramate made you foggy, propranolol made you tired, amitriptyline was its own negotiation. The newer antibody drugs your neurologist mentioned are expensive, insurance coverage is inconsistent, and the waiting list at the headache clinic is four months.
PE-22-28 — the short neuropeptide for mood, memory, and cognitive resilience
It's two in the afternoon and you haven't started the thing you were supposed to start at nine. Not because you've been distracted — you've been sitting at the desk, roughly aimed at the work, just not doing it. The ceiling feels lower than usual. The inside of your head has a particular quality to it: not the sharp absence of sleep deprivation, not the flat numbness of serious depression, just a muted, frictionful kind of gray. You're functional. You're also, clearly, not at your best. And the standard advice — sleep, exercise, get some sunlight — is correct and insufficient.
Restaurants used to be fine — when noise processing changes
You used to enjoy a busy restaurant. The noise was part of it — the hum of other conversations, the kitchen sounds, the social density of a room where everyone had somewhere to be. Now you sit down in that same kind of room and something is different. Following the conversation across the table requires an effort that didn't use to be required. You find yourself leaning in more, concentrating harder, asking people to repeat things. By the time the main course arrives you're running a low-level effort expenditure that has nothing to do with the food or the company. By the end of the evening you're tired in a way that can't quite be attributed to the late hour.
The headache after screens — what your after-work temple pain is signaling
By four in the afternoon there's a dull pressure starting at your temples, the kind that feels like it's coming from just behind the eyes and slowly tightening a band across the front of your head. The eyes themselves are dry and faintly burning, gritty when you blink, and the screen you've stared at through six hours of video calls and documents has taken on a slightly swimmy quality that makes you want to rub them. You close the laptop at the end of the day and the headache doesn't close with it — it rides home with you, settling in for the evening, a small tax levied for the work you just did with your eyes.
The vertigo spells you can't explain
It comes without warning, or it comes when you turn a certain way — roll over in bed, look up at a high shelf, turn your head quickly to the right. The room tilts. Not metaphorically. The room actually tilts, spinning or shifting in a way that has no relationship to any movement you've made, and for a few seconds or a few minutes the floor is unreliable. Sometimes there's nausea. Sometimes there's a cold sweat. Sometimes it passes in thirty seconds and you're left standing very still, waiting to be sure it's over. Sometimes it doesn't pass quickly and you end up sitting on the floor of a grocery store waiting for the world to settle. You describe this to your doctor and they say it sounds like benign positional vertigo, give you a handout about the Epley maneuver, and that's the end of it.
The vagus nerve, deeper — afferents, the inflammatory reflex, and the polyvagal debate
In 1998, an immunologist named Kevin Tracey was testing an experimental anti-inflammatory drug in the brains of rats, expecting it to act only inside the skull. Instead, when he injected the compound into the brain, inflammation dropped throughout the body, far from the injection site, and faster than any blood-borne signal could have traveled. The result made no sense under the prevailing model, in which inflammation was governed by molecules diffusing through the bloodstream. Tracey reasoned that something faster than chemistry must be carrying the message — something electrical. He cut the vagus nerve in the rats, repeated the experiment, and the anti-inflammatory effect vanished. The brain had been using the vagus nerve as a wire to switch off inflammation in the body. That single experiment opened a field, and it is the right place to begin a deeper look at a nerve most people think they already understand.